A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Conditions
Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Esophageal Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope National Medical Center /ID# 268690, Duarte, California, United States
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 272630, Irvine, California, United States
UCLA - Santa Monica /ID# 270024, Santa Monica, California, United States
AdventHealth Orlando /ID# 268561, Orlando, Florida, United States
City Of Hope - Atlanta. /ID# 280646, Newnan, Georgia, United States
Hattiesburg Clinic /ID# 268572, Hattiesburg, Mississippi, United States
Duke University Medical Center /ID# 268186, Durham, North Carolina, United States
Millennium Research & Clinical Development /ID# 268540, Houston, Texas, United States
Algemeen Ziekenhuis klina /ID# 268754, Brasschaat, Antwerpen, Belgium
Universitair Ziekenhuis Leuven /ID# 269957, Leuven, Vlaams-Brabant, Belgium
CHU de Liege /ID# 270223, Liège, Belgium
Princess Margaret Cancer Centre /ID# 268277, Toronto, Ontario, Canada
Centre Hospitalier de l'Universite de Montreal (CHUM) /ID# 268763, Montreal, Quebec, Canada
Jewish General Hospital /ID# 268413, Montreal, Quebec, Canada
Beijing Cancer Hospital /ID# 268455, Beijing, Beijing Municipality, China
Cancer Hospital Chinese Academy of Medical Sciences(Langfang) /ID# 277479, Langfang, Hebei, China
Harbin Medical University Cancer Hospital /ID# 268452, Harbin, Heilongjiang, China
Union Hospital - Tongji Medical College /ID# 268796, Wuhan, Hubei, China
The first Affiliated Hospital, Zhejiang University School of Medicine. /ID# 268782, Hangzhou, Zhejiang, China
Universitaetsklinikum Freiburg /ID# 270407, Freiburg im Breisgau, Baden-Wurttemberg, Germany
TUM Klinikum rechts der Isar /ID# 267792, Munich, Bavaria, Germany
Krankenhaus Nordwest /ID# 268462, Frankfurt am Main, Hesse, Germany
Universitaetsklinikum Leipzig /ID# 270432, Leipzig, Saxony, Germany
Haematologisch-Onkologische Praxis Eppendorf /ID# 268024, Hamburg, Germany
Meir Medical Center /ID# 267998, Kfar Saba, Central District, Israel
Soroka Medical Center /ID# 268301, Beersheba, Southern District, Israel
Tel Aviv Sourasky Medical Center /ID# 267755, Tel Aviv, Tel Aviv, Israel
Shaare Zedek Medical Center /ID# 267752, Jerusalem, Israel
Hadassah Medical Center-Hebrew University /ID# 267753, Jerusalem, Israel
Aichi Cancer Center /ID# 268124, Nagoya, Aichi-ken, Japan
National Cancer Center Hospital East /ID# 268083, Kashiwa-shi, Chiba, Japan
Shizuoka Cancer Center /ID# 268123, Sunto-gun, Shizuoka, Japan
National Cancer Center Hospital /ID# 268648, Chuo-Ku, Tokyo, Japan
The Cancer Institute Hospital Of JFCR /ID# 268656, Koto-ku, Tokyo, Japan
Pan American Center for Oncology Trials /ID# 268833, Rio Piedras, Puerto Rico
Hospital Universitario de Navarra /ID# 270119, Pamplona, Navarre, Spain
Hospital General Universitario Gregorio Maranon /ID# 270037, Madrid, Spain
Complexo Hospitalario Universitario de Ourense /ID# 270042, Ourense, Spain
Hospital Clinico Universitario de Valencia /ID# 270040, Valencia, Spain
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 267672, Kaohsiung City, Taiwan
China Medical University Hospital /ID# 267667, Taichung, Taiwan
National Cheng Kung University Hospital /ID# 267669, Tainan, Taiwan
National Taiwan University Hospital /ID# 267666, Taipei, Taiwan
Taipei Veterans General Hospital /ID# 267664, Taipei, Taiwan
Linkou Chang Gung Memorial Hospital /ID# 267668, Taoyuan City, Taiwan
Barts Health NHS Trust /ID# 270796, London, Greater London, United Kingdom
Oxford University Hospital NHS Trust /ID# 274614, Oxford, Oxfordshire, United Kingdom
Queen Elizabeth Hospital Birmingham /ID# 271199, Birmingham, United Kingdom
NHS Tayside Health Board /ID# 270799, Dundee, United Kingdom
Study leads
ABBVIE INC.
Study Director
AbbVie